NCM·Healthcare·$1.2B·#177 / 520 in Healthcare
NEO NeoGenomics, Inc.
55SPECULATIVE
CATEGORY BREAKDOWN
GROWTH16
QUALITY43
STABILITY85
VALUATION97
GOVERNANCE40
METRIC BREAKDOWN
Revenue Growth (YoY)
Year-over-year revenue growth rate
+10.1%
16
> 50% strong
Gross Margin
Revenue retained after direct costs
43.2%
60
> 50% strong
Cash Runway
Months of cash at current burn rate
999 months
100
> 24 months ideal
Debt / Equity
Total debt relative to shareholder equity
48.9%
56
< 25% strong
Price / Sales
Market cap relative to trailing revenue
1.6x
97
< 3x strong
Rule of 40
Growth rate plus operating margin
-2
18
> 40 excellent
Insider Ownership
Percentage of shares held by insiders
1.6%
13
> 20% strong
Share Dilution (12M)
Share count increase over last 12 months
+1.2%
93
< 5% ideal
SCORE HISTORY
RELATED STOCKS
COMPARE NEO WITH…
OR QUICK-COMPARE SECTOR PEERS
SCORE ALERT
Get notified when NEO's score changes by 5+ points.
DATA INFO
Last updated: May 4, 2026
Sources: SEC EDGAR, Financial Modeling Prep, Yahoo Finance. Not financial advice.